Cargando…
Ligustrazine monomer against cerebral ischemia/reperfusion injury
Ligustrazine (2,3,5,6-tetramethylpyrazine) is a major active ingredient of the Szechwan lovage rhizome and is extensively used in treatment of ischemic cerebrovascular disease. The mechanism of action of ligustrazine use against ischemic cerebrovascular diseases remains unclear at present. This stud...
Autores principales: | Gao, Hai-jun, Liu, Peng-fei, Li, Pei-wen, Huang, Zhuo-yan, Yu, Feng-bo, Lei, Ting, Chen, Yong, Cheng, Ye, Mu, Qing-chun, Huang, Hai-yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468780/ https://www.ncbi.nlm.nih.gov/pubmed/26109963 http://dx.doi.org/10.4103/1673-5374.156991 |
Ejemplares similares
-
Ligustrazine Nanoparticle Hitchhiking on Neutrophils for Enhanced Therapy of Cerebral Ischemia‐Reperfusion Injury
por: Mu, Qingchun, et al.
Publicado: (2023) -
Synergic Effect of Borneol and Ligustrazine on the Neuroprotection in Global Cerebral Ischemia/Reperfusion Injury: A Region-Specificity Study
por: Yu, Bin, et al.
Publicado: (2016) -
Ligustrazine Exerts Cardioprotection in Animal Models of Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms
por: Zheng, Qun, et al.
Publicado: (2018) -
Effect of Salvia miltiorrhiza and ligustrazine injection on myocardial ischemia/reperfusion and hypoxia/reoxygenation injury
por: Huang, Wendong, et al.
Publicado: (2016) -
The combination of Astragalus membranaceus and ligustrazine mitigates cerebral ischemia‐reperfusion injury via regulating NR2B‐ERK/CREB signaling
por: Tang, Xialing, et al.
Publicado: (2022)